News Release
Past news
- 2012.03.21
(40KB)
- Noven Pharmaceuticals, Inc. press release : Noven completes Phase3 clinical program for investigational non-hormonal therapy for menopausal vasomotor symptoms
- 2012.01.17(83KB)
- Regarding the Capital and Business Partnership with Yutoku Pharmaceutical lnd. Co., Ltd.
- 2012.01.12
- FY02/2012 Q3 Results Earnings Release Presentation
- 2011.12.26(35KB)
- Noven Pharmaceuticals, Inc. press release : Noven announces Phase3 results for investigational non-hormonal therapy for vasomotor symptoms
- 2011.10.27(32KB)
- Announcement on the Establishment of a Local Corporation in China
- 2011.10.17(28KB)
- Noven Pharmaceuticals, Inc. press release : Noven files patent infrigement lawsuit against Watson Pharmaceuticals
- 2011.10.12
- FY02/2012 Q2 Results Earnings Release Presentation
- 2011.09.21(12KB)
- Notification of Termination of Agreement Concerning Co-promotion of Fosamac®
- 2011.08.11(12KB)
- Phase III Clinical Trial Results for Overactive Bladder Drug HOB-294
(Oxybutynin Hydrochloride, Transdermal Therapeutic Formulation)
- 2011.07.21(41KB)
- Notice of the availability of Norspan® Tape, a dermally absorbed remedy for persistent pain.
- 2011.07.07(83KB)
- Announcement on Estimated Business Results and Dividends
- 2011.07.07
- FY02/2012 Q1 Results Earnings Release Presentation
- 2011.05.26(32KB)
- Notice of Personnel Changes
- 2011.04.15(12KB)
- Announcement Regarding the Impact of the Great Eastern Earthquake (3rd)
- 2011.04.08
- FY02/2011 Q4 Results Earnings Release Presentation
- 2011.03.25(37KB)
- Notice of Appointment of Executive Officer
- 2011.03.25(38KB)
- Notice of Proposed Changes of Directors and Auditors
- 2011.03.23(12KB)
- Announcement Regarding the Impact of the Tohoku-Pacific Ocean Earthquake (2nd)
- 2011.03.15(17KB)
- Notice concerning the decision of matters relating to acquisition of company’s own shares.
(Acquisition of company’s own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
- 2011.03.15(13KB)
- Announcement Regarding the Impact of the Tohoku-Pacific Ocean Earthquake
- 2011.03.15(9KB)
- Announcement Regarding Relief Money for the Tohoku-Pacific Ocean Earthquake
- 2011.02.23(23KB)
- Announcement of the acquisition of marketing approval for transdermal long-acting chronic pain "NORSPAN® TAPE" (development code: BTDS)
- 2011.02.23(24KB)
- Transdermal Pain Reliever and Anti-Inflammatory "Mohrus Tape®" (Development Code: KPT-220)
Notice Pertaining the Acquisition of Approval to Add the Effects Related to "Pain and Inflammation Relief for Acute Disorders and Symptoms"
- 2011.02.22(52KB)
- Noven Pharmaceuticals, Inc. press release : Noven files patent infrigement lawsuit against Mylan Technologies
- 2011.01.06
- FY02/2011 Q3 Results Earnings Release Presentation
- 2010.10.05
- FY02/2011 Q2 Results Earnings Release Presentation
- 2010.10.01(72KB)
- Noven Pharmaceuticals, Inc. press release : Noven completes acquisition of Daytrana® methylphenidate transdermal system (CII) from Shire
- 2010.08.27(13KB)
- Conduct ofAdditional Clinical Study of KW-2246, a Cancer Pain Drug
- 2010.08.11(77KB)
- Noven Pharmaceuticals, Inc. press release : Noven to acquire Daytrana® methylphenidate transdermal system from Shire
- 2010.06.30
- FY02/2011 Q1 Results Earnings Release Presentation
- 2010.06.14(26KB)
- Financial Support to SAGA Heavy Ion Medical Accelerator in Tosu Project
- 2010.06.11(16KB)
- Announcement of Listing of "FENTOS® TAPE," a transdermal, long-acting cancer pain relief patch, on the NHI Drug Price Standard
- 2010.05.26(11KB)
- Notice of Application for Delisting of Stock on Osaka Stock Exchange
- 2010.05.26(51KB)
- Notice of Personnel Changes
- 2010.04.23(11KB)
- Results of Phase III Clinical Trial of HKT-500 in the USA
- 2010.04.16(13KB)
- Hisamitsu Pharmaceutical Announces Marketing Approval of FENTOS® TAPE (Development Code: HFT-290), Transdermal, Long-Acting Cancer Pain Relief Patch
- 2010.04.08
- FY02/2010 Q4 Results Earnings Release Presentation
- 2010.03.25(19KB)
- Hisamitsu Announces U.S. Launch of its "Fentanyl Transdermal System" for the Management of Chronic Pain
- 2010.03.24(42KB)
- Revision of Earnings Forecast
- 2010.02.25(15KB)
- Application Filed for Cancer Pain Drug (KW-2246)
- 2010.02.01(13KB)
- Kyowa Hakko Kirin and Hisamitsu entered into a Joint Distribution Agreement on Cancer Pain Drug (Development Code: KW-2246)
- 2010.01.08
- FY02/2010 Q3 Results Earnings Release Presentation
- 2009.12.11(76KB)
- Notice concerning acquisition result and acquisition end of company?fs own shares. (Acquisition of company?fs own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
- 2009.12.03(62KB)
- Investment in Kind to our Subsidiary in the US
- 2009.11.12(17KB)
- Notice concerning the decision of matters relating to acquisition of company's own shares. (Acquisition of company's own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
- 2009.11.09(22KB)
- Additional Indication (For relief of local pain associated with rheumatoid arthritis) Approved for "MOHRUS Tape," a topical analgesic and anti-inflammatory product (Development Code: KPT-220)
- 2009.10.19(97KB)
- Hisamitsu Announces FDA Approval of its Fentanyl Transdermal System for Management of Chronic Pain (Development code: HFG-512)
- 2009.09.30
- FY02/2010 Q2 Results Earnings Release Presentation
- 2009.08.28(43KB)
- Completion of the tender offer for acquisition of shares of Noven Pharmaceuticals, Inc. by our subsidiary
- 2009.08.25(42KB)
- Results of a Phase II clinical study of HTU-520 (terbinafine hydrochloride, patch), atherapeutic agent for tinea unguium
- 2009.08.21(94KB)
- Results of tender offer for acquisition of Noven Pharmaceuticals, Inc. by our subsidiary
- 2009.08.06(30KB)
- Phase II study results of HOB-294 (transdermal oxybutynin hydrochloride) for treatment of overactive bladder
- 2009.07.27(308KB)
- The 4th Medium Term Management Plan
- 2009.07.27(25KB)
- 4th Medium-term Management Objectives
- 2009.07.14(129KB)
- Acquisition of Noven Pharmaceuticals,Inc.
- 2009.07.14(74KB)
- Hisamitsu to Acquire US-based Noven Pharmaceuticals Inc.
- 2009.06.30
- FY02/2010 Q1 Results Earnings Release Presentation
- 2009.04.07
- FY02/2009 Q4 Results Earnings Release Presentation
- 2009.03.24(67KB)
- Modification of Earnings Forecast
- 2009.03.18(30KB)
- Notice concerning acquisition result and acquisition end of company's own shares.
- 2009.02.26(37KB)
- Notice concerning the decision of matters relating to acquisition of company's own shares.
- 2009.01.23(23KB)
- Co-Promotion Agreement of "FOSAMAC"
- 2008.12.25
- FY02/2009 Q3 Results Earnings Release Presentation
- 2008.10.31(12KB)
- Application filed for a transdermal patch containing buprenorphine designed to control moderate to severe, chronic lower back and osteoarthritis pain (Development code: BTDS)
- 2008.10.09
- FY02/2009 Q2 Results Earnings Pelease Presentation
- 2008.09.25(93KB)
- Notice Regarding Performance Forecasts
- 2008.07.01
- FY02/2009 Q1 Results Earnings Pelease Presentation
- 2008.06.26(31KB)
- Application filed for a transdermal absorption-type continuous-action drugto treat cancer pain(Development code: HFT-290)
- 2008.06.18(31KB)
- Conclusion of a joint sales agreement on a transdermal absorption-type continuous-action drug to treat cancer pain(Development code: HFT-290)
- 2008.04.08
- FY02/2008 Q4 Results Earnings Pelease Presentation
- 2008.03.27(150KB)
- Information on Countermeasures(Takeover Defenses) for Large-scale Purchases of Hisamitsu Stock
- 2008.02.22(18KB)
- Press Release relating to FDA Approval for SALONPASR PAIN RELEAF PATCH (code: FS-67, topical analgesic product) under NDA
- 2007.12.27
- FY02/2008 Q3 Results Earnings Pelease Presentation
- 2007.08.06(40KB)
- Press Release relating to the Exclusive Sales and Distribution Rights for NORSPAN
- 2006.09.26
- SALONPAS CUP 2006 - International women's volleyball tournaments in Sao Paulo, Brazil
topics
table of games and results
more details
- 2005.11.01(196KB)
- FINANCIAL REPORT Fiscal 2005
- 2005.08.24
- SALONPAS CUP 2005 - International women's volleyball tournaments August 26 to September 3 in Sao Paulo, Brazil
topics
table of games and results
more details
- 2004.10.04
- SALONPAS CUP 2004 International women?fs volleyball tournaments October 2 to 10 in Sao Paulo,Brazil
organization
table of games and results
more details
topics
- 2003.07.01
- PT.Salonpas Indonesia has changed its company name to PT.Hisamitsu Pharma Indonesia
- 2003.05.26
- "SALONPAS CUP" (International Tournament of Women's Volley Ball in Brazil) home page renovated
- 2003.03.10
- Our Home Page Completely Renovated
- 2002.10.04
- Announcing the interim-closing brief report for the FY 2002 (ended February 2003)
- 2002.10.04
- Announcement of the Sales Contract Agreement of "KETOPATCH", the External Pain Relieving Drug for Medical Application with SIGMA-TAU (Italy)
